The Scientist

» FDA and developmental biology

Most Recent

image: FDA Approves 3-D–Printed Drug

FDA Approves 3-D–Printed Drug

By | August 4, 2015

The US Food and Drug Administration green lights the first medicine produced by a 3-D printer for use in the human body.

1 Comment

image: A Case of Sexual Ambiguity, 1865

A Case of Sexual Ambiguity, 1865

By | August 1, 2015

This year marks the 150th anniversary of an autopsy report describing the first known case of a sexual development disorder.

0 Comments

image: Contributors

Contributors

By | August 1, 2015

Meet some of the people featured in the August 2015 issue of The Scientist.

0 Comments

image: Leaving an Imprint

Leaving an Imprint

By | August 1, 2015

Among the first to discover epigenetic reprogramming during mammalian development, Wolf Reik has been studying the dynamics of the epigenome for 30 years.

1 Comment

image: Mimicry Muses

Mimicry Muses

By | August 1, 2015

The animal world is full of clever solutions to bioengineering challenges.

0 Comments

image: Mr. Epigenetics

Mr. Epigenetics

By | August 1, 2015

Meet Wolf Reik, August Profilee and Babraham Institute director of research.

0 Comments

image: Rethinking Lymphatic Development

Rethinking Lymphatic Development

By | August 1, 2015

Four studies identify alternative origins for cells of the developing lymphatic system, challenging the long-standing view that they all come from veins.

1 Comment

image: The Prescient Placenta

The Prescient Placenta

By | August 1, 2015

The maternal-fetal interface plays important roles in the health of both mother and baby, even after birth.

1 Comment

image: FDA OKs Herpes Blood Test

FDA OKs Herpes Blood Test

By | July 6, 2015

The US Food and Drug Administration approves Theranos’s fingerstick test for herpes.

0 Comments

image: Anti-Vax Doctor Found Dead

Anti-Vax Doctor Found Dead

By | June 30, 2015

Police are calling the death of James Bradstreet, a physician who claimed vaccines cause autism and offered autism cures to patients, an apparent suicide.

2 Comments

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Human Cord Plasma Protein Boosts Cognitive Function in Older Mice
AAAS